ArticleInternational ophthalmology2026
Bilateral fuchs uveitis syndrome and its association with multiple sclerosis.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the prevalence of multiple sclerosis (MS) among bilateral Fuchs uveitis syndrome (FUS) cases and compare their clinical characteristics with unilateral cases.
methodsPatients with bilateral FUS (Study group) and unilateral FUS (Control group) were reviewed retrospectively. All patients in the study group underwent fluorescein angiography (FA) and magnetic resonance imaging (MRI) and neurological consultation. Whereas in the control group, patients with posterior segment involvement underwent FA. MRI and neurological consultation were performed on patients with neurological symptoms. The relationship between MS diagnosis and data was evaluated.
resultsForty eyes of 20 patients in the study group and 40 eyes of 40 patients in the control group were included. Neurological evaluations revealed that 15% (3/20) of the patients in the study group diagnosed with MS, whereas neurologic symptoms were observed in one patient in the control group; however, MRI findings did not support a diagnosis of MS. Study group showed a higher prevalence of diffuse keratic precipitates (p < 0.001, χ2 test), while iris nodule subtypes differed between groups, with Busacca nodules predominating in study group and Koeppe nodules in control group (p = 0.019, p = 0.008 respectively, χ2 test). There was no significant difference between MS and non-MS eyes with fundus and FA findings (p > 0.05, χ2 test).
conclusionThe frequency of MS disease was found to be higher in bilateral FUS patients than in unilateral FUS cases. MS should be kept in mind in the diagnosis and follow-up of patients with bilateral FUS, and neurological investigations should be carried out when necessary.
Indexed as
Identifiers
42142135What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.